Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 41


Lanthanide-Loaded Nanoparticles as Potential Fluorescent and Mass Probes for High-Content Protein Analysis.

Ngamcherdtrakul W, Sangvanich T, Goodyear S, Reda M, Gu S, Castro DJ, Punnakitikashem P, Yantasee W.

Bioengineering (Basel). 2019 Mar 15;6(1). pii: E23. doi: 10.3390/bioengineering6010023.


Removal of a gadolinium based contrast agent by a novel sorbent hemoperfusion in a chronic kidney disease (CKD) rodent model.

Ngamcherdtrakul W, Morry J, Sangvanich T, Reda M, Bejan DS, Fryxell GE, Yantasee W.

Sci Rep. 2019 Jan 24;9(1):709. doi: 10.1038/s41598-018-37348-2.


Selective capture of radionuclides (U, Pu, Th, Am and Co) using functional nanoporous sorbents.

Yantasee W, Fryxell GE, Pattamakomsan K, Sangvanich T, Wiacek RJ, Busche B, Addleman RS, Timchalk C, Ngamcherdtrakul W, Siriwon N.

J Hazard Mater. 2019 Mar 15;366:677-683. doi: 10.1016/j.jhazmat.2018.12.043. Epub 2018 Dec 14.


Lyophilization and stability of antibody-conjugated mesoporous silica nanoparticle with cationic polymer and PEG for siRNA delivery.

Ngamcherdtrakul W, Sangvanich T, Reda M, Gu S, Bejan D, Yantasee W.

Int J Nanomedicine. 2018 Jul 10;13:4015-4027. doi: 10.2147/IJN.S164393. eCollection 2018.


Lack of acquired resistance in HER2-positive breast cancer cells after long-term HER2 siRNA nanoparticle treatment.

Gu S, Ngamcherdtrakul W, Reda M, Hu Z, Gray JW, Yantasee W.

PLoS One. 2018 Jun 7;13(6):e0198141. doi: 10.1371/journal.pone.0198141. eCollection 2018.


Targeted Treatment of Metastatic Breast Cancer by PLK1 siRNA Delivered by an Antioxidant Nanoparticle Platform.

Morry J, Ngamcherdtrakul W, Gu S, Reda M, Castro DJ, Sangvanich T, Gray JW, Yantasee W.

Mol Cancer Ther. 2017 Apr;16(4):763-772. doi: 10.1158/1535-7163.MCT-16-0644. Epub 2017 Jan 30.


Oxidative stress in cancer and fibrosis: Opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticles.

Morry J, Ngamcherdtrakul W, Yantasee W.

Redox Biol. 2017 Apr;11:240-253. doi: 10.1016/j.redox.2016.12.011. Epub 2016 Dec 16. Review.


Current development of targeted oligonucleotide-based cancer therapies: Perspective on HER2-positive breast cancer treatment.

Ngamcherdtrakul W, Castro DJ, Gu S, Morry J, Reda M, Gray JW, Yantasee W.

Cancer Treat Rev. 2016 Apr;45:19-29. doi: 10.1016/j.ctrv.2016.02.005. Epub 2016 Feb 22. Review.


Therapeutic siRNA for drug-resistant HER2-positive breast cancer.

Gu S, Hu Z, Ngamcherdtrakul W, Castro DJ, Morry J, Reda MM, Gray JW, Yantasee W.

Oncotarget. 2016 Mar 22;7(12):14727-41. doi: 10.18632/oncotarget.7409.


Dermal delivery of HSP47 siRNA with NOX4-modulating mesoporous silica-based nanoparticles for treating fibrosis.

Morry J, Ngamcherdtrakul W, Gu S, Goodyear SM, Castro DJ, Reda MM, Sangvanich T, Yantasee W.

Biomaterials. 2015 Oct;66:41-52. doi: 10.1016/j.biomaterials.2015.07.005. Epub 2015 Jul 10. Erratum in: Biomaterials. 2016 Jan;74:292.


Cationic Polymer Modified Mesoporous Silica Nanoparticles for Targeted SiRNA Delivery to HER2+ Breast Cancer.

Ngamcherdtrakul W, Morry J, Gu S, Castro DJ, Goodyear SM, Sangvanich T, Reda MM, Lee R, Mihelic SA, Beckman BL, Hu Z, Gray JW, Yantasee W.

Adv Funct Mater. 2015 May 13;25(18):2646-2659.


Nanoporous sorbent material as an oral phosphate binder and for aqueous phosphate, chromate, and arsenate removal.

Sangvanich T, Ngamcherdtrakul W, Lee R, Morry J, Castro D, Fryxell GE, Yantasee W.

J Nanomed Nanotechnol. 2014;5. pii: 1000222.


Novel oral detoxification of mercury, cadmium, and lead with thiol-modified nanoporous silica.

Sangvanich T, Morry J, Fox C, Ngamcherdtrakul W, Goodyear S, Castro D, Fryxell GE, Addleman RS, Summers AO, Yantasee W.

ACS Appl Mater Interfaces. 2014 Apr 23;6(8):5483-93. doi: 10.1021/am5007707. Epub 2014 Apr 4. Erratum in: ACS Appl Mater Interfaces. 2014 Dec 10;6(23):21750.


Improved deposition and deprotection of silane tethered 3,4 hydroxypyridinone (HOPO) ligands on functionalized nanoporous silica.

Davidson JD, Wiacek RJ, Burton S, Li XS, Fryxell GE, Addleman RS, Yantasee W, Sangvanich T, Pattamakomsan K.

Inorg Chem Commun. 2012 Apr;18:92-96.


Functionalized nanoporous silica for the removal of heavy metals from biological systems: adsorption and application.

Yantasee W, Rutledge RD, Chouyyok W, Sukwarotwat V, Orr G, Warner CL, Warner MG, Fryxell GE, Wiacek RJ, Timchalk C, Addleman RS.

ACS Appl Mater Interfaces. 2010 Oct;2(10):2749-58. doi: 10.1021/am100616b.


In vitro and in vivo evaluation of a novel ferrocyanide functionalized nanopourous silica decorporation agent for cesium in rats.

Timchalk C, Creim JA, Sukwarotwat V, Wiacek R, Addleman RS, Fryxell GE, Yantasee W.

Health Phys. 2010 Sep;99(3):420-9. doi: 10.1097/HP.0b013e3181bca9b0.


Functional sorbents for selective capture of plutonium, americium, uranium, and thorium in blood.

Yantasee W, Sangvanich T, Creim JA, Pattamakomsan K, Wiacek RJ, Fryxell GE, Addleman RS, Timchalk C.

Health Phys. 2010 Sep;99(3):413-9. doi: 10.1097/HP.0b013e3181ce5f3e.


Selective removal of copper(II) from natural waters by nanoporous sorbents functionalized with chelating diamines.

Chouyyok W, Shin Y, Davidson J, Samuels WD, LaFemina NH, Rutledge RD, Fryxell GE, Sangvanich T, Yantasee W.

Environ Sci Technol. 2010 Aug 15;44(16):6390-5. doi: 10.1021/es101165c.


Selective capture of cesium and thallium from natural waters and simulated wastes with copper ferrocyanide functionalized mesoporous silica.

Sangvanich T, Sukwarotwat V, Wiacek RJ, Grudzien RM, Fryxell GE, Addleman RS, Timchalk C, Yantasee W.

J Hazard Mater. 2010 Oct 15;182(1-3):225-31. doi: 10.1016/j.jhazmat.2010.06.019. Epub 2010 Jun 11.


High-performance, superparamagnetic, nanoparticle-based heavy metal sorbents for removal of contaminants from natural waters.

Warner CL, Addleman RS, Cinson AD, Droubay TC, Engelhard MH, Nash MA, Yantasee W, Warner MG.

ChemSusChem. 2010 Jun 21;3(6):749-57. doi: 10.1002/cssc.201000027.


Supplemental Content

Loading ...
Support Center